Telehealth and RPM Security Review

Telehealth and RPM Security Review

Telehealth and remote patient monitoring security does not stop at a video platform or connected device. A real workflow can cross the patient home, a mobile app or hub, a carrier, a telehealth platform, cloud services, identity systems, support tools, the EHR, clinical queues, and downstream records. The buyer needs evidence for that whole chain, not a single badge or questionnaire.

Use this guide to review one named workflow, product, device, module, software version, configuration, population, and environment. It is a buyer-owned method for collecting and testing evidence. It does not determine legal applicability, certify a product, replace clinical safety review, or provide a universal architecture.

The output is a bounded internal decision with owners, open risks, evidence dates, an expiry, and recheck triggers. It is not a public statement that a vendor is compliant, approved, safe, effective, or risk free.

How to run the review

Start before contracting or connecting real patient data. Name the decision owner, the proposed use, the systems and people affected, and the evidence needed at each gate.

Use the HIPAA / BAA Evidence Checklist to organize relationship and contract questions without treating a completed form as approval.

Use the PHI Use Risk Analyzer to expose proposed data uses and unresolved ownership before a live connection is permitted.

Keep supplier claims separate from buyer observation. A policy, architecture diagram, BAA, certification, penetration-test summary, software bill of materials, or incident plan can be useful supplier documented evidence. It does not show that the buyer's configured workflow operated as expected.

Use synthetic or approved test data for configured scenarios. Preserve expected behavior, observed behavior, logs, alerts, timestamps, defects, remediation, retest results, limitations, and the exact environment. This guide does not claim that any such local test has already occurred.

Treat material privacy, integrity, availability, clinical-safety, device-lifecycle, incident-response, or recovery gaps as non-compensating. They cannot be offset by a weighted total, lower price, more features, popularity, or projected savings.

Gate 1: freeze scope, actors, and regulatory lanes

Define the care setting, telehealth modality, RPM condition or program, patient cohort, location, organization, product, device, module, software version, intended use, and deployment model. List what is included and excluded. A narrow pilot decision must not silently become permission for another population, jurisdiction, modality, or workflow.

Name every actor that creates, receives, maintains, transmits, administers, supports, or acts on the data. Include the healthcare organization, clinicians, RPM staff, patients and caregivers, the platform vendor, device manufacturer, cloud and identity providers, subprocessors, integration partners, and support teams where they actually participate.

Route legal questions instead of answering them with a product label. HIPAA covered-entity and business-associate status, the FTC Health Breach Notification Rule, medical-device status, state law, contractual duties, and local policy depend on the facts. Security reviewers record questions and evidence; authorized privacy, legal, compliance, regulatory, and device owners decide applicability.

Evidence request: Provide a signed scope charter and actor list. Record the product, device, module, version, intended use, data categories, locations, populations, included and excluded workflows, regulatory questions, reviewers, and decision authority.

Stop rule: Stop if the workflow, product identity, responsible entity, data boundary, intended use, or accountable owner is unknown. A vendor category, marketing name, or generic compliance statement is not a frozen scope.

Gate 2: map the end-to-end architecture and data inventory

Trace the workflow from enrollment and device or visit setup through capture, transmission, storage, thresholding, queue review, clinician action, documentation, support, export, backup, deletion, and program discharge. Draw the patient home, device, app or hub, network, platform, cloud, identity service, EHR, analytics, support, and administrative paths that actually exist.

Inventory readings, alerts, thresholds, messages, recordings, transcripts, images, identifiers, consent records, visit content, device metadata, support artifacts, audit events, exports, and backups only where the proposed workflow creates them. For each item, record source, destination, transformation, copy, retention, authoritative system, derived status, correction path, and owner.

Reconcile supplier diagrams with contracts, configuration, interface specifications, data samples, logs, and buyer observation. The map must show privileged and support access, subprocessor flows, telemetry, tracking technologies, test environments, and termination paths when present. An unexplained copy or transfer remains open.

Evidence request: Provide an architecture diagram and data-flow inventory for the named version and environment. Mark trust boundaries, interface directions, storage, backups, logs, support, subprocessors, exports, deletion, authoritative records, owners, and exclusions.

Hold rule: Hold when a material flow, copy, subprocessor, privileged path, authoritative record, data location, backup, export, or deletion route cannot be reconciled to evidence.

Gate 3: verify identity, authority, and privileged access

Map identities for patients, caregivers, clinicians, RPM staff, support personnel, vendor administrators, service accounts, APIs, devices, and emergency access. For each identity, record enrollment, proofing or binding, authentication, authorization, provisioning, periodic review, revocation, recovery, and session termination.

Test role, patient, program, tenant, device, purpose, and environment boundaries that matter to the workflow. Include denied access, wrong patient, wrong tenant, excessive privilege, expired or revoked credentials, lost devices, support impersonation, shared accounts, session lock, and emergency access. A successful login does not prove appropriate authority.

Privileged access requires named approval, minimum duration, monitored use, reviewable logs, and prompt removal. Record who can alter thresholds, routing, device assignments, identity mappings, retention, logs, exports, or integrations, and whether the buyer can reconstruct those changes.

Evidence request: Provide the identity model, role matrix, and device-binding method. Add authentication, sessions, MFA applicability, privileged access, service accounts, credential ownership, reviews, revocation, emergency access, logs, and configured negative-test results.

Stop rule: Stop if unauthorized cross-patient or cross-tenant access succeeds, privileged access is unowned or unlogged, critical credentials cannot be revoked, or device and patient identity cannot be reliably bound in the named workflow.

Gate 4: verify data protection and lifecycle controls

Review protection during capture, transmission, storage, backup, export, support, testing, and deletion. Record protocols and configurations rather than accepting the word encrypted. Name key and secret ownership, rotation, recovery, administrative access, and any component that can see unencrypted data.

Separate confidentiality, integrity, and availability. Encryption can reduce some disclosure risks but does not prove that readings are complete, correctly attributed, timely, recoverable, or available when needed. Check missing, duplicated, stale, delayed, altered, or misrouted readings and messages, including how users see uncertainty.

Define retention and disposal by data class. Cover platform data, recordings, transcripts, messages, device data, alerts, audit logs, backups, support tickets, analytics, test artifacts, exports, and termination copies where applicable. Contract terms, system configuration, actual behavior, and evidence of return or deletion must agree.

Evidence request: Provide data-protection configurations and name key and secret owners. Add integrity controls, retention, backup and restore, deletion and return, tracking, analytics, test and support data, locations, subprocessors, termination evidence, and buyer-observed lifecycle tests.

Hold rule: Hold when protection, integrity, retention, backup, export, tracking, deletion, key ownership, or termination behavior is undocumented, contradictory, untestable, or broader than the approved scope.

Gate 5: review device, integration, and change risk

Freeze the exact device, model, software, firmware, app, module, API, interface, configuration, and intended use. Do not infer that every RPM component is a medical device. When a component is actually a medical device, route classification and regulatory-record questions to qualified owners and bind evidence to the exact identity and use.

Request vulnerability intake, coordinated disclosure, dependency and software bill of materials information where available, patch and update policy, update authenticity, supported configurations, end-of-support dates, known limitations, compensating controls, and safety-impact escalation. Supplier material remains supplier documented until reconciled to the deployed scope.

For each interface and EHR write-back path, test authentication, authorization, schema and value validation, timestamps, patient and device association, replay, duplication, missing or stale data, queue failure, partial delivery, retry, rollback, affected-record enumeration, and reconciliation. Define what happens when a security patch affects clinical or operational behavior.

Evidence request: Provide the device and software inventory, intended use, regulatory route, supported configuration, and dependencies. Add vulnerability intake, disclosure, software bill of materials availability, patches, support and end-of-support plans, change notices, interface rules, rollback, regression evidence, and re-test triggers.

Stop rule: Stop when the buyer cannot identify the deployed component and version, a material unsupported component has no bounded mitigation, a critical interface can silently misattribute data, or change and rollback authority is absent.

Gate 6: exercise availability, detection, and incident response

Define the events that must be logged across patient, workforce, device, platform, cloud, integration, support, and administrative paths. Verify identity and context, clock handling, tamper signals, retention, access to logs, cross-system correlation, alerts, human review, investigation access, and affected-record enumeration.

Exercise realistic failure and incident scenarios with approved data. Include lost connectivity, device failure, unavailable platform or cloud, identity-provider outage, delayed or missing readings, compromised account or device, unauthorized support access, bad threshold change, notification failure, unpatched component, log gap, data export, and EHR interface disruption.

For each scenario, preserve expected and observed behavior, detection, containment, evidence preservation, vendor notification, clinical and operational fallback, patient communication owner, restoration, backlog handling, reconciliation, findings, correction, retest, and residual risk. A written plan without an exercised handoff remains supplier documented.

Evidence request: Provide the event and alert catalogue, log settings, access model, contacts, notice terms, and escalation authority. Add containment, credential rotation, downtime, backup, recovery, scenarios, exercise records, affected-record search, restored-state proof, reconciliation, findings, owners, and retests.

Stop rule: Stop when a material event is undetectable, evidence cannot be preserved, containment authority is unclear, a safe downtime path is absent, recovery cannot be demonstrated, or restored records and alerts cannot be reconciled.

Gate 7: include the patient home and access boundary

The patient home is part of the operating environment, but it is not an institutionally managed network. Record device custody, shared devices and accounts, physical privacy, home connectivity assumptions, charging and update needs, caregiver roles, legitimate support contacts, loss or replacement paths, and safe fallback when technology is unavailable.

Give patients usable information about the technology and vendor, privacy and security precautions, recordings or tracking where applicable, update prompts, phishing and contact verification, support, corrections, and escalation. Provide accessible formats, language support, and alternatives appropriate to the intended population. Patient instructions do not transfer institutional or vendor control obligations to the patient.

Test how the workflow exposes stale, missing, implausible, delayed, or misattributed data to patients and staff. Make clear who monitors information, during which hours, what is not continuously monitored, what constitutes an emergency, and how a patient reaches an appropriate channel without relying on a security marketing claim.

Evidence request: Provide patient setup, security, privacy, recording, custody, accessibility, and language materials. Add support and contact verification, updates, replacement, caregiver and shared-account controls, connectivity assumptions, fallback, escalation, and approved usability and downtime evidence.

Open rule: Keep the gate open when patient instructions, accessibility, language support, custody, shared-use controls, support verification, fallback, or monitoring expectations do not match the named population and workflow.

Gate 8: record a bounded, expiring decision

Summarize every gate as passed, failed, held, or conditionally approved only for the named scope. Preserve evidence links, source class, verifier, date, limitations, open questions, compensating controls, dissent, remediation owner, decision authority, expiry, and next review date.

Do not average away hard stops. A strong feature set, contract, certification, low price, projected utilization, or attractive business case cannot compensate for an unknown data flow, unauthorized access, unresolved integrity failure, missing incident path, unsafe downtime, unsupported device, or unreconciled recovery.

Define triggers that reopen the review: product, device, module, software, firmware, configuration, intended use, population, location, data class, interface, identity provider, subprocessor, support status, vulnerability, incident, contract, law, guidance, workflow, staffing, or evidence-validity changes. Expansion is a new decision, not an automatic benefit of a prior pilot.

Evidence request: Provide the gate record, evidence register, hard stops, exceptions, controls, risks, approvals, dissent, scope, version, expiry, and recheck triggers. Add renewal and expansion limits, termination, revocation, data disposition, reconciliation, dependency removal, and decommissioning proof.

Stop rule: Do not issue a pass or conditional approval without a named scope/version, accountable authority, evidence dates, open-risk treatment, expiry, and recheck triggers. An unbounded or permanent approval is invalid.

Questions by accountable owner

Use these questions to assign work. A missing answer stays open; it does not become not applicable by default.

Workflow, clinical operations, and patient-support owners

• Name the modality, workflow, condition, cohort, location, hours, product, device, module, and version. What downstream action is in scope?
• Name who reviews readings and alerts, the operating window, and the escalation and stop authority. How are missing, stale, delayed, implausible, or misattributed signals made visible?
• Check setup, privacy, security, contact routes, support, corrections, access needs, language, downtime, and emergency limits. Can patients and caregivers understand them?

Privacy, legal, and compliance owners

• Identify the data, metadata, and every copy in the actual relationship. Which entities are covered entities, business associates, subcontractors, conduits, non-HIPAA app actors, or other regulated actors?
• Compare the BAA, SLA, privacy, security, subprocessor, incident, retention, return, deletion, audit, exit, and responsibility terms with the real architecture. Do they match the intended use?
• List the HIPAA, FTC, FDA, state, contract, privacy, accessibility, and other issues. Which need a qualified decision, and which remain unresolved?

Security operations, IAM, and incident owners

• List patients, caregivers, clinicians, support staff, vendor administrators, service accounts, and devices. How is each identity bound, authenticated, authorized, reviewed, monitored, and revoked?
• Define the access, configuration, export, threshold, integration, support, device, and admin events that need logs. Who can read or alter them, and how are correlation, alerts, review, and affected-record search verified?
• Define each incident class and its authority chain. Who detects, declares, contains, preserves evidence, rotates credentials, notifies parties, runs fallback, restores service, reconciles records, and closes actions?

Architecture, integration, device, and cloud owners

• Inventory systems, devices, apps, carriers, platforms, cloud, identity, interfaces, subprocessors, support paths, copies, and trust boundaries. Which records are authoritative?
• Identify any medical device and its exact model, software, configuration, and support status. How are vulnerabilities, dependencies, patches, updates, end of support, rollback, and safety impact managed?
• Define behavior for duplicate, delayed, missing, stale, malformed, out-of-range, replayed, or misattributed data and interface failure. How are affected records, restored queues, and downstream systems reconciled?

Procurement, vendor-risk, continuity, and decision owners

• Bind supplier claims, contracts, assurance reports, test summaries, certifications, software bills of materials, incident records, support statements, and notices to the exact scope. Where are the limitations?
• Define the safe workflow for device, connectivity, platform, cloud, identity, interface, EHR, staffing, or support disruption. What observed evidence proves recovery and reconciliation?
• Mark hard failures and the findings that permit only a named condition. Who accepts risk, when does the decision expire, and which changes force renewed review?

Five buyer-owned security artifacts

These artifacts remain owned by the buyer even when a supplier contributes evidence. Each record should include issuer, document or version, status and date, accessed or observed date, applies to, does not apply to, evidence class, owner, limitation, expiry, recheck trigger, finding, and next action.

A. Scope, actor, and regulatory-routing charter

Record the organization, location, setting, modality, workflow, population, product, device, module, version, intended use, and configuration. Add actors, roles, included and excluded data and uses, decision authority, and possible HIPAA, FTC, FDA, state, contract, and local-policy lanes.

This charter records questions and accountable reviewers. It does not itself decide legal applicability, medical-device status, compliance, clinical safety, or approval.

B. Architecture, data-flow, and responsibility map

Trace the patient home through device, app or hub, carrier, platform, cloud, identity, support, analytics, integration, EHR, queues, exports, backups, and deletion. Record data classes, copies, direction, transformation, and location. Mark the authoritative system, trust boundary, privileged path, control owner, subprocessor, and termination path.

Attach supplier diagrams, configuration, contracts, interface specifications, log samples, approved observations, discrepancies, and unresolved flows. Keep supplier representation and buyer reconciliation visibly separate.

C. Identity, device, and change-control register

Record human, service, API, and device identities. Add enrollment, binding, roles, authentication, authorization, privileged access, credentials, reviews, and revocation. Then record device model, software, firmware, configuration, intended use, dependencies, vulnerabilities, patches, support, notices, rollback, and re-test triggers.

Bind every item to the named environment. A company-level policy or product-family statement is not evidence for an unidentified component or configuration.

D. Logging, incident, downtime, and recovery test packet

Store required events, log sources, identity and context, time handling, protection, retention, correlation, alerts, review, investigation access, and affected-record search. Add incident contacts, notice terms, containment, evidence preservation, downtime, fallback authority, restoration, backlog, reconciliation, findings, corrections, and retests.

For each configured scenario, preserve expected and observed behavior, synthetic or approved data, environment, version, timestamps, logs, alerts, defects, limitations, owners, remediation, and decision effect. A plan alone is not an exercised result.

E. Evidence and decision register

Map each requirement to its evidence class, source, exact product, version, environment, date, limitation, and verifier. Record the finding, status, open risk, mitigation, owner, decision, expiry, and recheck trigger. Preserve negative results, conflicts, superseded evidence, exceptions, and dissent.

Keep termination and exit evidence in the same record: access revocation, credential rotation, data return or deletion, retained logs, queue closure, record reconciliation, dependency removal, and decommissioning.

Evidence classes and decision states

Do not mix sources with different authority or scope. Use these six evidence classes.

Law and case-specific record

law / regulation / case-specific regulatory record applies only to the named jurisdiction, entity, product, function, and facts. Qualified owners retain legal and regulatory interpretation.

Regulator guidance

regulator guidance explains an agency's position or recommendations within its stated scope. It is not product certification or proof of local control effectiveness.

Voluntary practice material

voluntary standard / practice guide supplies risk, control, or implementation methods. It does not establish compliance or require every non-federal organization to use one design.

Supplier evidence

supplier documented includes contracts, diagrams, policies, certifications, reports, software bills of materials, incident history, support statements, test summaries, and change notices. Keep the claim, scope, version, date, limitation, and verification status.

Buyer observation

buyer observed means the buyer actually executed and recorded an approved configured test, log review, exercise, or pilot scenario for the named version and environment. Do not generalize it to another deployment or to the whole product.

Open or stale evidence

open / conflicting / expired / superseded covers missing, inconsistent, outdated, replaced, or out-of-scope evidence. No blank field becomes a pass.

Use four bounded decision states: fail; hold — material evidence missing; conditional approval for named scope/version; pass for named scope/version. Conditional and pass decisions still need owners, evidence, open-risk treatment, expiry, and recheck triggers. They are not a public product endorsement.

Current official-source boundaries

Official material helps teams frame questions and identify scope. It does not replace a local, product-specific decision.

Telehealth status and HIPAA risk analysis

The HHS OCR telehealth hub records that the COVID-19 telehealth enforcement-discretion notifications ended May 11, 2023. Do not treat the pandemic posture as a continuing exception.

The HHS OCR audio-only telehealth guidance distinguishes traditional landlines from electronic communication technologies for covered entities. It supports questions about interception, encryption, recordings, transcripts, authentication, session controls, inventory, and relationship-specific business-associate analysis. It is not a rule for every telehealth or consumer app.

The HHS OCR risk-analysis guidance supports identifying where ePHI is created, received, maintained, or transmitted and assessing confidentiality, integrity, and availability in the regulated organization's environment. It rejects a one-size-fits-all blueprint.

The ONC/OCR Security Risk Assessment Tool page displays v3.7 for small and medium providers. The tool is not exhaustive, is not legal advice, and does not guarantee compliance.

RPM ecosystem and cloud responsibility

NIST SP 1800-30 is a 2022 final practice guide built around a three-domain laboratory example: a healthcare delivery organization, a separate telehealth platform provider, and a patient home. It is not a law, certification, or universal architecture, and its example does not validate a named product or different operating model.

The HHS OCR cloud guidance supports responsibility, BAA, risk-analysis, availability, backup, recovery, retention, return, termination, and incident questions for in-scope cloud arrangements. A signed BAA or encrypted service does not prove the rest of the security review passed.

The HHS healthcare-provider patient resource supports questions about technology identity, privacy and security practices, tracking, phishing, updates, support, accessibility, and language. The resource says this patient education is not independently required by the HIPAA Rules; education does not transfer institutional controls to the patient.

Medical-device and healthcare practice lanes

The FDA cybersecurity hub points to the June 27, 2025 final guidance that superseded the 2023 guidance of the same title. Use it only when the component is actually a medical device and the exact device, intended use, model, software, version, configuration, and regulatory context match. It does not turn every telehealth platform, RPM service, or wellness app into a device.

The HHS Health Industry Cybersecurity Practices gateway labels HICP as the 2023 Edition and as recommendations and best practices. It can inform governance, identity, vulnerability, network-connected-device, incident, and recovery questions, but it is not a legal safe harbor, product certification, or sufficient proof.

Non-HIPAA app and workflow lanes

The FTC Health Breach Notification Rule page and FTC business guidance state that the 2024 amendments became effective July 29, 2024 and clarify coverage of many health apps, connected devices, and similar technologies not covered by HIPAA. Not HIPAA does not mean unregulated, but coverage remains fact dependent.

The CMS remote patient monitoring explainer supports workflow definition only: patient setup, a connected medical device, digital transmission, provider review, and communication. It does not provide a cybersecurity standard, product approval, HIPAA or FDA status, case-specific coverage, or proof that a control operated.

The HHS mobile health app developer hub routes fact-specific questions across HIPAA, FTC, FDA, COPPA, and information-blocking topics. It does not create a single health-app law or an automatic actor classification.

FAQs

Is a BAA enough to approve a telehealth or RPM service?

No. A BAA may be required for an actual business-associate relationship, but it is one contract artifact. It does not prove a complete data inventory, appropriate access, configured protection, accurate logging, incident readiness, recovery, deletion, or the buyer's own obligations. Legal and privacy owners decide applicability from the actual parties, service, data, and workflow.

Does encryption mean the data flow passes?

No. Record exact protocols, configurations, key ownership, administrative access, rotation, recovery, and exceptions. Then assess integrity and availability as well as confidentiality. Encrypted data can still be incomplete, stale, misattributed, unrecoverable, or unavailable.

Does an assurance report or certification replace local testing?

No. It can be supplier documented evidence for the named scope and period. Record exclusions, findings, complementary controls, product coverage, configuration differences, expiry, and reliance limits. Local configured results remain a separate evidence class.

Is every RPM product a medical device?

No. Function and intended use matter, and the exact component requires qualified review. Do not apply device guidance to an unidentified platform or infer approval from a company, family, registration, or unrelated product record.

Is every security incident a reportable breach?

No universal conclusion follows from the label incident. Preserve evidence, contain the event, enumerate affected people and records, and escalate promptly. Qualified privacy and legal owners determine applicable definitions, assessments, documentation, and notices from the facts.

When should an approval expire or reopen?

Set an expiry even when all gates pass. Reopen for changes in product, device, software, firmware, configuration, intended use, data, population, location, interface, identity, subprocessor, support, vulnerability, incident, contract, workflow, staffing, law, guidance, or evidence validity. A prior decision does not automatically cover expansion.

Handoff to adjacent decision pages

Use the telehealth and RPM buyer checklist for procurement completeness, owners, and minimum evidence requests. It does not verify configured control effectiveness.

Use the telehealth and RPM compliance questions for legal and compliance applicability, privacy duties, contracts, and required notices. This security method records technical and operational evidence but does not issue legal conclusions.

Use the telehealth and RPM vendor evaluation guide for cross-vendor finalist comparison under a common scope and scenario set. A comparison score does not override a security hard stop.

Use the telehealth and RPM workflow implementation guide for configured implementation, cutover, downtime, rollback, reconciliation, and operating monitoring after selection.

Use the telehealth and RPM pilot planning guide for bounded local execution with an approved population, environment, metrics, and stop rules. Pilot evidence does not generalize beyond its recorded boundary.

These pages exchange evidence and decisions, but each retains its accountable owner and does not complete their reviews.

Evidence boundary

This guide synthesizes public official sources and creates an editorial buyer framework. It does not claim access to vendor portals, contracts, architecture, assurance reports, software bills of materials, vulnerability scans, penetration tests, packet captures, incident logs, configured products, buyer environments, named device records, state-law analyses, or patient data.

No vendor rating, product test, vulnerability status, incident rate, uptime, response time, device accuracy, patient outcome, customer interview, local result, clinical conclusion, compliance finding, approval, cost, traffic, or conversion result is claimed. Supplier documents remain supplier documented; buyer-observed evidence remains absent until a buyer actually creates and retains it.

The generic author and reviewer fields in the page record do not establish named clinical, legal, privacy, security, regulatory, or device-professional signoff. Qualified local owners must review the facts and evidence for the actual decision.

Continue your HealthAIdir research

• Start with AI for telehealth operations and AI for HIPAA compliance to map the operating and privacy context.
• Use the HIPAA / BAA Evidence Checklist to organize relationship, contract, hosting, subprocessor, incident, retention, and exit questions without treating the checklist as approval.
• Use the PHI Use Risk Analyzer to document proposed data uses and unresolved ownership questions before testing a real workflow.
• Review telehealth, role-based access control, data retention, and audit log for shared terminology.